First Foundation Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.24M Buy
18,637
+3,938
+27% +$455K 0.09% 136
2025
Q4
$1.55M Buy
14,699
+403
+3% +$37.8K 0.06% 147
2025
Q3
$1.2M Buy
14,296
+948
+7% +$78.1K 0.04% 169
2025
Q2
$1.06M Buy
13,348
+2,236
+20% +$178K 0.04% 183
2025
Q1
$997K Sell
11,112
-1,689
-13% -$158K 0.04% 167
2024
Q4
$1.27M Sell
12,801
-743
-5% -$76.6K 0.05% 154
2024
Q3
$1.54M Sell
13,544
-1,231
-8% -$146K 0.06% 146
2024
Q2
$1.83M Sell
14,775
-705
-5% -$90.8K 0.07% 125
2024
Q1
$2.04M Buy
15,480
+624
+4% +$76.9K 0.08% 116
2023
Q4
$1.62M Sell
14,856
-5,921
-28% -$615K 0.07% 131
2023
Q3
$2.14M Sell
20,777
-672
-3% -$72.4K 0.1% 122
2023
Q2
$2.47M Buy
21,449
+50
+0.2% +$5.68K 0.11% 120
2023
Q1
$2.28M Sell
21,399
-15,979
-43% -$1.73M 0.1% 121
2022
Q4
$4.15M Buy
37,378
+616
+2% +$63K 0.2% 84
2022
Q3
$3.17M Buy
36,762
+5,468
+17% +$488K 0.16% 91
2022
Q2
$2.85M Sell
31,294
-11
-0% -$975 0.13% 103
2022
Q1
$2.57M Buy
31,305
+5,789
+23% +$456K 0.09% 118
2021
Q4
$1.96M Buy
25,516
+2,711
+12% +$216K 0.07% 137
2021
Q3
$1.71M Buy
22,805
+1,472
+7% +$112K 0.06% 151
2021
Q2
$1.66M Sell
21,333
-10,913
-34% -$812K 0.06% 159
2021
Q1
$2.37M Buy
32,246
+13,461
+72% +$993K 0.1% 119
2020
Q4
$1.47M Buy
18,785
+560
+3% +$42.8K 0.07% 154
2020
Q3
$1.44M Buy
18,225
+934
+5% +$73.2K 0.07% 147
2020
Q2
$1.28M Sell
17,291
-931
-5% -$70.1K 0.07% 151
2020
Q1
$1.34M Buy
18,222
+2,213
+14% +$174K 0.08% 137
2019
Q4
$1.39M Sell
16,009
-127
-0.8% -$10.4K 0.07% 157
2019
Q3
$1.3M Sell
16,136
-1,127
-7% -$90.3K 0.07% 146
2019
Q2
$1.38M Buy
17,263
+1,457
+9% +$112K 0.08% 148
2019
Q1
$1.25M Sell
15,806
-421
-3% -$31.5K 0.07% 151
2018
Q4
$1.18M Sell
16,227
-620
-4% -$43.8K 0.07% 162
2018
Q3
$1.14M Sell
16,847
-558
-3% -$35.5K 0.06% 155
2018
Q2
$1.01M Buy
17,405
+2,091
+14% +$118K 0.06% 159
2018
Q1
$796K Sell
15,314
-4,026
-21% -$217K 0.04% 179
2017
Q4
$1.04M Sell
19,340
-4,002
-17% -$222K 0.06% 173
2017
Q3
$1.43M Sell
23,342
-5,025
-18% -$305K 0.08% 127
2017
Q2
$1.74M Sell
28,367
-469,885
-94% -$28.6M 0.1% 117
2017
Q1
$30.2M Buy
498,252
+20,517
+4% +$1.24M 1.87% 19
2016
Q4
$26.8M Buy
477,735
+34,003
+8% +$1.99M 1.76% 19
2016
Q3
$26.4M Sell
443,732
-9,121
-2% -$533K 1.83% 14
2016
Q2
$24.9M Buy
452,853
+774
+0.2% +$41.2K 1.79% 17
2016
Q1
$22.8M Sell
452,079
-18,337
-4% -$898K 1.66% 20
2015
Q4
$23.7M Buy
470,416
+86,895
+23% +$4.38M 1.62% 19
2015
Q3
$18.1M Buy
383,521
+349,127
+1,015% +$18.5M 1.48% 22
2015
Q2
$1.87M Buy
34,394
+18,157
+112% +$1.02M 0.15% 84
2015
Q1
$891K Buy
16,237
+3,147
+24% +$178K 0.07% 111
2014
Q4
$709K Sell
13,090
-157
-1% -$8.75K 0.06% 120
2014
Q3
$749K Buy
13,247
+77
+0.6% +$4.32K 0.07% 108
2014
Q2
$727K Sell
13,170
-453
-3% -$24.7K 0.08% 94
2014
Q1
$738K Buy
13,623
+6,699
+97% +$347K 0.09% 76
2013
Q4
$331K Buy
6,924
+371
+6% +$17K 0.04% 139
2013
Q3
$298K Buy
6,553
+1,367
+26% +$62.4K 0.05% 129
2013
Q2
$230K Buy
+5,186
New +$232K 0.05% 117

Other funds holding MRK

First Foundation Advisors's MRK Position: Q1 2026 in Review

First Foundation Advisors increased its Merck (MRK) stake by 27% in Q1 2026, buying an estimated $455K and bringing the position to 18,637 shares worth $2.24M. The position accounts for 0.09% of the portfolio, ranked #136.

First Foundation Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.2M in Q1 2017. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • First Foundation Advisors held 18,637 shares of Merck worth $2.24M as of Q1 2026.
  • First Foundation Advisors bought 3,938 Merck shares in Q1 2026, an estimated $455K.
  • Merck made up 0.09% of First Foundation Advisors's portfolio in Q1 2026, its #136 holding.
  • First Foundation Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • First Foundation Advisors's Merck position peaked at $30.2M in Q1 2017.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on First Foundation Advisors's 13F filing for Q1 2026, filed 4 May 2026.